Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix.

Competing Interests: Conflict of interest statement AMDG has served as a consultant and/or advisor to Incyte, Pierre Fabre, Glaxo Smith Kline, Bristol-Myers Squibb, Merck Sharp Dohme, and Sanofi, and has received compensated educational activities from Bristol Myers Squibb, Merck Sharp Dohme, Pierre Fabre, and Sanofi. MM has served as a consultant and/or advisor to Roche, Bristol-Myers Squibb, Merck Sharp Dohme, Incyte, AstraZeneca, Amgen, Pierre Fabre, Eli Lilly, Glaxo Smith Kline, Sciclone, Sanofi, Alfasigma, and Merck Serono, and owns shares in Epigen Therapeutics, Srl. GG, CG, MFL, and MGC declare no conflicts of interest.